AARTIINDBSEAarti Industries Ltd· Chemicals & PetrochemicalsHighPositive
Announced Mon, 4 May, 2026 · 18:51 IST

PFA Press Release on the Audited Financial Results of the Company for the Quarter and Year Ended March 31, 2026.

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

AARTIIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.1%Reaction day
₹513.00
prior close
₹513.05
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%-5.3% vs market
Specialty Chemicals peers, median of 94sector-0.1%-5.0% vs sector

On the reaction day the stock moved 5.3 pts less than Nifty Smallcap 250 and 5.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.1
10m
-4.6
15m
-4.5
30m
-4.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.1+0.2-5.3-0.1-5.0
Next day
-3.3+2.0-5.3+1.5-4.8
2d
-4.7+3.0-7.7+2.6-7.3
3d
-5.1+3.2-8.3+3.1-8.2
4d
-5.4+2.1-7.5+1.1-6.5
5d
-8.4-0.9-7.4-0.9-7.5
1w
-8.6-0.6-8.0+0.4-9.0
15d
-4.3+0.7-5.0+0.6-4.9
1m
-10.5+0.9-11.4-1.8-8.7
2m
-4.9+7.0-11.9+2.6-7.5
3m
-5.3+8.4-13.7+5.6-10.9
UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Industries reported Q4 FY26 consolidated income from operations of ₹2,422 Cr and full-year FY26 revenue of ₹9,018 Cr, reflecting 12% YoY growth. Full-year EBITDA stood at ₹1,172 Cr (up 15% YoY) and PAT at ₹419 Cr (up 27% YoY). Q4 included a ₹39 Cr revaluation loss on foreign-currency loans due to INR depreciation. The company secured two strategic deals: a ₹200-250 Cr backward integration project with a global chemical company over 15 years, and a $150 million multi-year agrochemical supply agreement through March 2030. Management flagged ongoing Middle East geopolitical risks affecting feedstock availability but remains cautiously optimistic for FY27.

Likely market impact

Strong full-year performance with 27% PAT growth and 15% EBITDA growth demonstrates operational resilience. The long-term contracts enhance earnings visibility and support sustained growth trajectory despite near-term geopolitical headwinds.